Double Blind Study to Determine Effect of Omalizumab Treatment in Patients With the Co-Morbid Conditions of Aspirin Exacerbated Respiratory Disease(AERD) and Allergic Asthma and Rhinitis.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma; Allergic rhinitis; Aspirin-induced asthma
- Focus Therapeutic Use
- 28 Feb 2017 New trial record